IP Library Granted Patent US 10,443,077
Granted Patent B2
US 10,443,077 · App. 15/550,894 · Granted Oct 15, 2019

Fermentation process for producing itaconic acid under nitrogen free conditions

Inventors: Ruud Weusthuis (Wageningen, NL); Kiira Vuoristo (Wageningen, NL); Gerrit Eggink (Wageningen, NL); Johan Pieter Marinus Sanders (Wageningen, NL)
Assignee: DSM IP ASSETS B.V.
C12P7/44C12N9/88C12N15/52C12Y401/01006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,443,077
App. No.
15/550,894
Granted
Oct 15, 2019
Kind
B2
Abstract

The present invention relates to a method for the production of itaconic acid, which method comprises fermenting a recombinant cell capable of producing itaconic acid in a suitable fermentation medium, thereby to produce itaconic acid, wherein: (a) the recombinant cell: (i) overexpresses cis-aconitate decarboxylase; and (ii) overexpresses a part of the citric acid cycle and/or has reduced activity of a native metabolic route to acetate and/or lactate; and, optionally, (b) the fermentation is carried out under anaerobic conditions.

Claims (16)

1. A method for the production of itaconic acid, which method comprises fermenting a recombinant cell selected from a bacterial cell or a yeast cell capable of producing itaconic acid in a suitable fermentation medium, thereby to produce itaconic acid, wherein:

(a) the recombinant cell: (i) overexpresses cis-aconitate decarboxylase; and (ii) overexpresses a part of the citric acid cycle and/or has reduced activity of a native metabolic route to acetate and/or lactate, wherein overexpression of a part of the citric acid cycle is overexpression of a citrate synthase and/or overexpression of an aconitase and wherein reduced activity of a native metabolic route to acetate is reduced activity of a phosphate acetyltransferase by deleting, disrupting or inactivating the pta gene in the recombinant cell and/or wherein reduced activity of a native metabolic route to lactate is reduced activity of a lactate dehydrogenase by deleting, disrupting or inactivating the ldhA gene in the recombinant cell; and,

(b) the fermentation is carried out under anaerobic conditions, wherein fermentation carried out under anaerobic conditions means a fermentation process run in the absence of oxygen or in which substantially no oxygen is consumed or a fermentation process run under oxygen limited, or micro-aerobical, conditions; and

(c) wherein glutamate production is repressed by carrying out the fermentation under nitrogen free conditions.

2. The method according to claim 1 , wherein the cis-aconitate decarboxylase is an Aspergillus terreus cis-aconitate decarboxylase.

3. The method according to claim 1 wherein production of itaconic acid is accompanied by either ethanol and formate production or H 2 and CO 2 production.

4. The method according to claim 1 , wherein the bacterial cell is E. coli , or wherein the yeast cell is S. cerevisiae.

5. The method according to claim 1 which comprises recovery of the itaconic acid.

6. A method for the production of itaconic acid, which method comprises fermenting a recombinant bacterial cell capable of producing itaconic acid in a suitable fermentation medium, thereby to produce itaconic acid, wherein:

(a) the recombinant cell: (i) overexpresses Aspergillus terreus cis-aconitate decarboxylase; and (ii) overexpresses a part of the citric acid cycle and has reduced activity of a native metabolic route to acetate and lactate, wherein overexpression of a part of the citric acid cycle is overexpression of the gltA gene coding for citrate synthase and overexpression of the acnA gene coding for aconitase and wherein reduced activity of a native metabolic route to acetate is reduced activity of a phosphate acetyltransferase by deleting, disrupting or inactivating the pta gene in the recombinant cell and wherein reduced activity of a native metabolic route to lactate is reduced activity of a lactate dehydrogenase by deleting, disrupting or inactivating the ldhA gene in the recombinant cell; and,

(b) the fermentation is carried out under anaerobic conditions, wherein fermentation carried out under anaerobic conditions means a fermentation process run in the absence of oxygen or in which substantially no oxygen is consumed or a fermentation process run under oxygen limited, or micro-aerobical, conditions; and,

(c) wherein glutamate production is repressed by carrying out the fermentation under nitrogen free conditions.

7. The method according to claim 6 wherein the recombinant bacterial cell is a recombinant E. coli cell.

8. The method according to claim 6 wherein in step (a) the citrate synthase is C. glutamicum citrate synthase.

9. The method according to claim 6 wherein in step (a) the aconitase is C. glutamicum aconitase.

10. The method according to claim 6 wherein in step (b) the fermentation process is run in the absence of oxygen or in which substantially no oxygen is consumed.

Assignments (4)
CHANGE OF CORPORATE ADDRESS Recorded Mar 30, 2022
From: COVESTRO (NETHERLANDS) B.V.
To: COVESTRO (NETHERLANDS) B.V.
Reel/Frame 059546/0570 →
CHANGE OF NAME Recorded Jul 2, 2021
From: MS HOLDING B.V.
To: COVESTRO (NETHERLANDS) B.V.
Reel/Frame 056756/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2021
From: DSM IP ASSETS B.V.
To: MS HOLDING B.V.
Reel/Frame 056726/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: WEUSTHUIS, RUUD; VUORISTO, KIIRA; EGGINK, GERRIT; SANDERS, JOHAN PIETER MARINUS
To: DSM IP ASSETS B.V.
Reel/Frame 045159/0156 →